Skip to content

Food and Drug Administration

Congress

Britt attacks use of synthetic food dyes, praises FDA phase out plan

Britt criticized artificial food dyes on social media, praising a Huntsville bakery and General Mills for eliminating them from products.
June 24, 2025

Aderholt assists Webb Diagnostics as they work on a rapid antibody test

Thursday, Nashville based Webb Diagnostics thanked Congressman Robert Aderholt (R-Haleyville) for his assistance in receiving emergency FDA approval for their innovative rapid antibody test to not only detect active COVID-19 infections; but also past exposure to the virus, possibly indicating immunity to the virus. This type of widespread, rapid testing is an important element in … Continued
April 27, 2020

Senate passes $8.3 billion in funding to deal with coronavirus

U.S. Sen. Richard Shelby on Thursday applauded the Senate’s passage of an emergency supplemental funding package to deal with the coronavirus. The legislation provides $8.3 billion in total resources to prevent, prepare for, and respond to the COVID-19 strain coronavirus. “I am pleased Congress has swiftly passed this emergency supplemental to combat the dangerous Coronavirus,” … Continued
March 6, 2020

House passes $7.7 billion supplemental funding package to address the coronavirus

Wednesday, the U.S. House of Representatives passed a robust emergency supplemental funding package to prevent, prepare for, and respond to the Coronavirus, the COVID-19 strain. The package – which provides $7.767 billion in emergency appropriations, more than triple the Administration’s original request. “I voted ‘yes’ today to provide an additional $7.8 billion to fight the … Continued
March 5, 2020

Medical experts sharply divided at Alabama Medical Cannabis Study Commission

Thursday, the Alabama Medical Cannabis Study Commission heard from two highly respected medical expert witnesses with widely divergent views on the wisdom of passing medical marijuana legislation. Bertha K. Madras is a professor of psychobiology in the Department of Psychiatry and the chair of the Division of Neurochemistry at Harvard Medical School, She served as … Continued
November 13, 2019

Jones: Time to take marijuana off controlled substances list

Thursday, U.S. Senator Doug Jones, D-Alabama, spoke with Alabama reporters on issues currently facing the state and the nation. During the call the issue of taking marijuana off of the federal controlled substances list came up. “I think it is about time that we moved it off the controlled states list,” Jones said. “This is … Continued
September 20, 2019